Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 26,607 | 26,384 | 24,724 | 23,499 | 20,123 |
| Gross Profit | 26,607 | 26,384 | 24,724 | 23,499 | 20,123 |
| Operating Expenses | 27,213 | 23,261 | 28,072 | 29,152 | 29,632 |
| Operating Income | -606 | 3,123 | -3,348 | -5,653 | -9,509 |
| Other Income | 2,512 | 2,692 | 2,261 | 2,342 | 733 |
| Pre-tax Income | 1,906 | 5,815 | -1,087 | -3,311 | -8,776 |
| Income Tax | 1,069 | 2,823 | N/A | N/A | N/A |
| Net Income Continuous | 837 | 2,992 | -1,087 | -3,311 | -8,776 |
| Net Income | $837 | $2,992 | $-1,087 | $-3,311 | $-8,776 |
| EPS Basic Total Ops | 0.02 | 0.04 | -0.02 | -0.05 | -0.13 |
| EPS Basic Continuous Ops | 0.02 | 0.04 | -0.02 | -0.05 | -0.13 |
| EPS Diluted Total Ops | 0.02 | 0.04 | -0.02 | -0.05 | -0.13 |
| EPS Diluted Continuous Ops | 0.02 | 0.04 | -0.02 | -0.05 | -0.13 |
| EBITDA(a) | $-2,346 | $1,674 | $-4,463 | $-6,593 | $-8,906 |